trending Market Intelligence /marketintelligence/en/news-insights/trending/93kPUHBdB6iiQYKt1nxsig2 content esgSubNav
In This List

Canadian cannabis company Delta 9 gets conditional approval to list on TSX

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Canadian cannabis company Delta 9 gets conditional approval to list on TSX

Delta 9 Cannabis Inc. received conditional approval to graduate from the TSX Venture Exchange and list on the TSX.

The Canadian cannabis company was given approval to list its common shares, common-share purchase warrants expiring Dec. 28, common-share purchase warrants expiring July 17, 2022, and 8.5% unsecured convertible debentures on the exchange.

Final approval is subject to Delta 9 meeting standard requirements on or before Nov. 5.

Upon completion of the final listing requirements, the company's common shares, two sets of warrants and debentures will be delisted from the TSX Venture Exchange and begin trading on the TSX under the DN, DN.WT, DN.WT.A and DN.DB ticker symbols, respectively.